focus -WSS

focus

author：Wikipedia 2025-09-06 03:28:29 - browse：34

The FDA building -- First Opinion coverage from STAT — Adobe

The Food and Drug Administration on Thursday released a new accounting of artificial intelligence tools cleared for use in health care, adding scores of new products designed to reshape care in several areas of medicine.

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

The list of AI devices was first published after a STAT investigation reported that the FDA had failed to keep the public informed on its regulation of AI devices, or crucial details on the tests undertaken to prove their safety and effectiveness. The summary documents that describe new AI devices often fail to break out the demographics of the patients they were tested on, or where the testing took place, which makes it difficult for clinicians and patients to understand their potential biases and weaknesses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Flu, Covid vaccination rates decline, new survey data show

WSS

The U.S. needs a new definition of substance use “recovery”

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

Biden’s NIH nominee is languishing in Congress

CDC picks Alphabet's Verily for wasterwater surveillance contract

DeSantis defends odds vs. Trump, despite early poll gap: 'We've worked really hard'

explore

focus

focus

Cancer drug shortages should be causing more outrage

The stability of $0 premiums in Medicare Advantage

At least 13 dead in Texas as scorching temps continue

Health insurers' Q3 question: how much care are people getting?

In Memoriam: Notable people who died in 2023

The U.S. needs a new definition of substance use “recovery”

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Setback for rare diseases as Taysha Gene Therapies pulls back

State Dept. review finds Biden bears some blame for Afghanistan failures

Flu, Covid vaccination rates decline, new survey data show

entertainment

What we owe ALS patients — and why one company fell short

Health insurers' Q3 question: how much care are people getting?

The stability of $0 premiums in Medicare Advantage

Parents surprise family after baby discharged from NICU after 170 days

The Karikó problem: Lessons for funding basic research

WHO recommends second malaria vaccine

entertainment

entertainment

hotspot

hotspot